Related references
Note: Only part of the references are listed.Substantial variation in the cardiac differentiation of human embryonic stem cell lines derived and propagated under the same conditionsa comparison of multiple cell lines
Mari Pekkanen-Mattila et al.
ANNALS OF MEDICINE (2009)
In Vitro Electrophysiological Drug Testing Using Human Embryonic Stem Cell Derived Cardiomyocytes
Oren Caspi et al.
STEM CELLS AND DEVELOPMENT (2009)
Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines
H. R. Lu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Strategies to reduce the risk of drug-induced QT interval prolongation: a pharmaceutical company perspective
C. E. Pollard et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Transcriptional and Functional Profiling of Human Embryonic Stem Cell-Derived Cardiomyocytes
Feng Cao et al.
PLOS ONE (2008)
The hERG potassium channel and hERG screening for drug-induced torsades de pointes
Jules C. Hancox et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Long QT Syndrome and Short QT Syndrome
Wojciech Zareba et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2008)
Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts
Michael A. Laflamme et al.
NATURE BIOTECHNOLOGY (2007)
L-type calcium current reactivation contributes to arrhythmogenesis associated with action potential triangulation
Donglin Guo et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2007)
Comparison of K+ currents in cardiac Purkinje cells isolated from rabbit and dog
Robert Dumaine et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: A molecular and electrophysiological approach
Laura Sartiani et al.
STEM CELLS (2007)
Restricting excessive cardiac action potential and QT prolongation -: A vital role for IKs in human ventricular muscle
N Jost et al.
CIRCULATION (2005)
Refining detection of drug-induced proarrhythmia: QT interval and TRIaD
RR Shah et al.
HEART RHYTHM (2005)
Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures
R Passier et al.
STEM CELLS (2005)
Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3
P Milberg et al.
CARDIOVASCULAR RESEARCH (2005)
Drug therapy: Drug-induced prolongation of the QT interval
DM Roden
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Phenotypic differences in transient outward K+ current of human and canine ventricular myocytes:: insights into molecular composition of ventricular Ito
FG Akar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes
J Satin et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
Microelectrode arrays: A new tool to measure embryonic heart activity
M Reppel et al.
JOURNAL OF ELECTROCARDIOLOGY (2004)
Assessing predictors of drug-induced torsade de pointes
L Belardinelli et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Human embryonic stem cells develop into multiple types of cardiac myocytes - Action potential characterization
JQ He et al.
CIRCULATION RESEARCH (2003)
Differentiation of human embryonic stem cells to cardiomyocytes - Role of coculture with visceral endoderm-like cells
C Mummery et al.
CIRCULATION (2003)
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
WS Redfern et al.
CARDIOVASCULAR RESEARCH (2003)
High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes - A novel in vitro model for the study of conduction
I Kehat et al.
CIRCULATION RESEARCH (2002)
Share Paper
